Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
The primary objective of the study is to assess the cardiac status of COVID-19 pneumonia patients during 1 year after discharge
Description: Echocardiographic assessment of global strain parameters at 3 and 12 months after discharge
Measure: Echocardiographic assessment of cardiac function Time: up to one yearDescription: Major adverse cardiac and cerebrovascular events: cardiac death, myocardial infarction, or stroke at 3 and 12 months after discharge
Measure: МАССЕ Time: up to one yearDescription: Describe the parenchymal lung damage through a quantitative analysis with chest CT at 3 and 12 months after discharge
Measure: Quantitative analysis of parenchymal lung damage Time: up to one yearDescription: Six-min walk test at 3 and 12 months after discharge
Measure: Functional exercises capacity assessment Time: up to one yearDescription: Measure of creatinine clearance at 3 and 12 months after discharge
Measure: Evaluation of renal function Time: up to one yearDescription: Analysis for C-reactive protein at 3 and 12 months after discharge
Measure: Evaluation of inflammation Time: up to one yearDescription: Analysis for activated clotting time at 3 and 12 months
Measure: Evaluation of coagulation abnormality Time: up to one yearDescription: Assessment of the Short Form Health Survey (SF36) at 3 and 12 months after discharge
Measure: Evaluation of quality of life in first year after discharge Time: up to one yearAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports